Copertina

Outcomes after treating advanced mantle cell lymphoma in a low‐income group at a Latin American center: The role of outpatient hematopoietic stem cell transplantation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	José Carlos Jaime‐Pérez, Marcela Hernández‐Coronado, Mariana González‐Treviño, Renata V. Barragán‐Longoria, Eugenia M. Ramos‐Dávila, David Gómez‐Almaguer
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Hematological Oncology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
di: Taku Kikuchi, et al.
Pubblicazione: (2024)

Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus‐associated mantle cell lymphoma
di: Jiangfang Feng, et al.
Pubblicazione: (2024)

Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario
di: Antonio Pinto, et al.
Pubblicazione: (2024)

Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients
di: Kaitlin Annunzio, et al.
Pubblicazione: (2024)

Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy
di: Hidehiro Itonaga, et al.
Pubblicazione: (2024)

Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan
di: Kenji Ishitsuka, et al.
Pubblicazione: (2024)

Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group
di: Evgenia Verrou, et al.
Pubblicazione: (2024)

Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study
di: Beatrice Casadei, et al.
Pubblicazione: (2024)

Metabolic pathway‐based subtyping reveals distinct microenvironmental states associated with diffuse large B‐cell lymphoma outcomes
di: Xiaohui Wang, et al.
Pubblicazione: (2024)

Bruton tyrosine kinase inhibitor monotherapy in B‐cell lymphoma and risk of infection: A systematic review and meta‐analysis of randomized controlled trials
di: Mohammed Zuber, et al.
Pubblicazione: (2024)

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203
di: Takashi Watanabe, et al.
Pubblicazione: (2024)

Efficacy of escalating therapy with brentuximab vedotin‐AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD
di: Carmen Martínez, et al.
Pubblicazione: (2024)

A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia
di: Sudhir Manda, et al.
Pubblicazione: (2024)

Characterizing second line and beyond therapies for primary central nervous system lymphomas
di: Brian Primeaux, et al.
Pubblicazione: (2024)

From trials to statistical insights: Bortezomib's story in childhood T‐cell lymphoid malignancies
di: Shyam Srinivasan
Pubblicazione: (2024)

New insights into the Bortezomib‐induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model
di: Maria Anele Romeo, et al.
Pubblicazione: (2024)

Antibody targeting of surface P‐selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition
di: João L. Pereira, et al.
Pubblicazione: (2024)

Real‐world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL‐CLLEAR study
di: Anna Panovská, et al.
Pubblicazione: (2024)

Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement
di: Elisabetta M. Abenavoli, et al.
Pubblicazione: (2024)

ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia
di: Zong‐Yan Shi, et al.
Pubblicazione: (2024)

The role of baseline 2‐[ 18 F]‐FDG‐PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis
di: Domenico Albano, et al.
Pubblicazione: (2024)

Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
di: Mariarita Sciumè, et al.
Pubblicazione: (2024)

The RAS‐signaling‐pathway‐mutation‐related prognosis in B‐cell acute lymphoblastic leukemia: A report from South China children's leukemia group
di: Xinyu Li, et al.
Pubblicazione: (2024)

Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides
di: Taku Fujimura, et al.
Pubblicazione: (2024)

Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax
di: Stefano Cordella, et al.
Pubblicazione: (2024)

Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
di: Caroline Le Lan, et al.
Pubblicazione: (2024)

Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real‐world clinical setting
di: Taku Kikuchi, et al.
Pubblicazione: (2024)

Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single‐center retrospective analysis
di: Marie Anne‐Catherine Neumann, et al.
Pubblicazione: (2024)

Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt‐related transcription factor 1 mutation: A single‐center retrospective analysis
di: Lin‐Ya Wang, et al.
Pubblicazione: (2024)

181 | MYC REARRANGEMENTS IN LARGE B‐CELL LYMPHOMAS: IMPACT OF THE BREAKPOINT AND PARTNER ON PROGNOSIS
di: M. Bastos‐Oreiro, et al.
Pubblicazione: (2025)

Efferocytosis and M2 Macrophage Polarization Gene Expression Correlates With Relapsed and Refractory Classical Hodgkin Lymphoma Patients: A Multi‐Omic Analysis
di: Juan Quarroz Braghini, et al.
Pubblicazione: (2025)

Clustering Based on Innate Immunity Reveals Differential Dysregulation Based on Disease Severity in Myelodysplastic Neoplasms
di: Pedro Robson Costa Passos, et al.
Pubblicazione: (2025)

MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia
di: Jana Gregorova, et al.
Pubblicazione: (2025)

Adoptive cellular therapy after hematopoietic stem cell transplantation
di: Pongthep Vittayawacharin, et al.
Pubblicazione: (2024)

520 | THE ROLE OF LABORATORY PROGNOSTIC INDEX AND METABOLIC TUMOR VOLUME IN PREDICTING DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS POTENTIALLY CURABLE WITH R‐CHOP
di: S. Browne Arthur, et al.
Pubblicazione: (2025)

CEBPA ‐bZIP Mutations in AML Patients Treated With Non‐Intensive Therapy: A Study by the Spanish PETHEMA Registry
di: Esther Prados de la Torre, et al.
Pubblicazione: (2026)

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell Lymphoma
di: Juliette Penichoux, et al.
Pubblicazione: (2025)

Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis
di: Maria Livia Del Giudice, et al.
Pubblicazione: (2024)

Upregulated miR‐29a‐3p Prevent Malignant Features of Lymphoma Cells by Targeting MCL1
di: Tengfei Shi, et al.
Pubblicazione: (2025)

Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma
di: Akihiko Izumi, et al.
Pubblicazione: (2025)